<!DOCTYPE html>
<html xmlns:og="http://opengraphprotocol.org/schema/">
    <head>
        <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no">
        <meta http-equiv="content-type" content="text/html; charset=utf-8" />
        <title>	2022-05478 - Post-Doctoral Research Visit F/M Post-doctoral research fellowship in modelling of the immune response to Ebola vaccine
</title>
        <link rel="icon" type="image/x-icon" href="../../../../favicon-16x16.png"/>
        <script type="text/javascript" src="../../../../js/jquery/jquery-1.9.1.js"></script>
        <script type="text/javascript" src="../../../../css/bootstrap-3.3.4/js/bootstrap.js"></script>
        	<meta property="og:description" content="Offre d'emploi Inria" />
	<meta property="og:title" content="Post-Doctoral Research Visit F/M Post-doctoral research fellowship in modelling of the immune response to Ebola vaccine" />
	<meta property="og:url" content="http://jobs.inria.fr/public/classic/fr/offres/2022-05478" />
	<meta property="og:locale" content="fr_FR" />
	<meta property="og:site_name" content="Inria"/>
	<meta property="og:type" content="article" />
        	            <link rel="stylesheet" href="../../../../css/bootstrap-3.3.4/css/bootstrap.min.css"/>
            <link rel="stylesheet" href="../../../../library/bootstrap-select-1.12.2/dist/css/bootstrap-select.min.css"/>
            <link rel="stylesheet" href="../../../../css/bootstrap/bootstrap-datetimepicker.css"/>
            <link rel="stylesheet" href="../../../../library/font-awesome-4.7.0/css/font-awesome.css"/>
            <link rel="stylesheet" href="../../../../css/fonts/fonts.css"/>
            <link rel="stylesheet" href="../../../../css/app/main_public.css" />
            <link rel="stylesheet" href="../../../../css/inria.css"/>
        
	<link property="stylesheet" rel="stylesheet" href="../../../../css/app/detailOffre.css" />
    </head>
<body  style="background-image: url('../../../../images/bg-jobs.png') ">
    
<nav id="toplinklist" class="nav navbar-nav navbar-default navbar-fixed-top" >
    <div class="navbar-inner">
        <div class="container">
            <div class="navbar-header">
                                <a href="../offres.html" class="pull-left inriatoplinklogo">
                    <img alt="Inria" width="30%" src="https://commons.inria.fr/images/logo/inr_logo_sans_sign_rouge.jpg" />
                </a>
                                <button type="button" class="navbar-toggle toplinktoggle" data-toggle="collapse" data-target="#navbar-collapse-menuTop">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse" id="navbar-collapse-menuTop">
                <ul class="nav navbar-nav navbar-right">
                                        <li class="visible-xs text-right toplinktoggle-remove nav-profil-menu" data-toggle="collapse" data-target="#navbar-collapse-menuTop">
                        <i class="inria-gray3 fa fa-remove fa-2x"></i></li>
                    <li class=" text-center picto-lang nav-profil-menu" >
                                                                         <span class="toplang-button">
                             <a class="a-inria" href="2022-05478.html" >FR</a> <span class="inria-gray2">|</span>
                             <a class="inria-gray2" href="https://jobs.inria.fr/public/classic/en/offres/2022-05478" title="English">
                                EN
                            </a>
                        </span>
                                            </li>

                                                                                                    <li class="dropdown text-center nav-profil-menu">
                        <a href="2022-05478.html#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">
                            <img alt="user" src="../../../../images/user.png">
                                                        <p style="color: black;">
                                Compte <span class="caret"></span>
                            </p>
                                                    </a>
                        <ul class="dropdown-menu">
                                                        <li><a href="../../../fr/connect.html"> <span class="fa fa-sign-in"></span> Se connecter</a></li>
                            <li><a href="../../../fr/register.html"><span class="fa fa-plus"></span> Créer un compte</a></li>
                                                    </ul>
                    </li>
                                </ul>
            </div><!-- /.navbar-collapse -->
          </div><!-- /.container -->
    </div><!-- /.navbar-inner -->
</nav>


<!-- Bouton Scroll -->
<div class="row">
    <div class="col-md-12">
        <div class="visible-sm visible-xs">
            <a href="2022-05478.html#" title="Haut de page" class="scrollup scrollup-sm link-btn" type="button">
                <i class="fa fa-chevron-up"></i>
            </a>
        </div>
        <div class="visible-md">
            <a href="2022-05478.html#" title="Haut de page" class="scrollup scrollup-md link-btn" type="button">
                <i class="fa fa-chevron-up"></i>
            </a>
        </div>
        <div class="visible-lg">
            <a href="2022-05478.html#" title="Haut de page" class="scrollup scrollup-lg link-btn" type="button">
                <i class="fa fa-chevron-up"></i>
            </a>
        </div>
    </div>
</div>
<!-- Main content -->
<div class="col-md-12 main-content" style="height:auto;">
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1 col-lg-8 col-lg-offset-2 menu-breadcrumb">
            <a href="https://jobs.inria.fr/public/classic/fr/offres?locale=fr" class="a-inria">
        Accueil
        </a>
         > 
        <a href="https://jobs.inria.fr/public/classic/fr/offres?locale=fr" class="a-inria">Liste des offres</a>
         > Détail d&#039;une offre        </div>
    </div>
    <div class="row" ><div  class="col-xs-10 col-xs-offset-1 col-md-8 col-lg-6 col-lg-offset-2"></div></div>
<div class="row">
    <div class="col-md-12 col-lg-10 col-lg-offset-1">
        <div class="row">
                    
                <div id="left" class="col-sm-7 col-lg-6 col-lg-offset-1 block-left">
                    <div class="list-group list-group-item" style="padding: 6%; font-size: 16px;">
                                              <div class="row">
                            <span class="h4-inria intitule-detail-offre col-xs-10 col-sm-11"> 
                                <b>2022-05478 - Post-Doctoral Research Visit F/M Post-doctoral research fellowship in modelling of the immune response to Ebola vaccine</b>
                            </span>
                            <span class=" col-xs-2 col-sm-1">
                            <a class="a-inria" class="pdf-link"  href="https://jobs.inria.fr/public/classic/fr/offres/2022-05478/topdf" title="PDF">
                            	<i class="fa fa-file-pdf-o fa-2x pull-right"></i>
                            </a>
                            </span> 
                        </div>
                        <div class="row">
                         <span class=" h4 col-xs-10 col-sm-11"> 
                                                                                   <i class="fa fa-info-circle"></i> <em>Le descriptif de l’offre ci-dessous est en Anglais</em>
                                                                               </span>
                        </div>
                                						
		<div class="grand-item-offre">
		
				<div class="item-offre">	    	
	    	<p class="list-group-item-text"><b>Type de contrat : </b>
	        	CDD
	        </p>	        
	    </div>
	    	    
	    	    
	    	    <div class="item-offre">
	    	<p class="list-group-item-text"><b>Niveau de diplôme exigé : </b>
	        	Thèse ou équivalent
	        </p>
	    </div>
	    	    
	    	    
	    	    
	    		<div class="item-offre">
	    	<p class="list-group-item-text"><b>Fonction : </b>
	        	Post-Doctorant
	        </p>
	    </div>
	    	    
	    	    
	    	    
	        </div>
    
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">A propos du centre ou de la direction fonctionnelle</h4>
    	<div class="list-group-item-text text-justify">
    		<p style="text-align: justify;">The challenge is to analyze these BIG DATA to answer clinical and biological questions by using appropriate statistical methods. With data on the machinery of a cell to the clinical status of individuals in any circumstances including in clinical trials, new tools are needed to translate information obtained from complex systems into knowledge. This has led to the field of &laquo;&nbsp;systems biology&nbsp;&raquo; and &laquo; systems medicine &raquo; by extension, which naturally takes place in the context of translational medicine that links clinical and biological research.</p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Contexte et atouts du poste</h4>
    	<div class="list-group-item-text text-justify">
    		<p style="text-align: justify;"><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 95.1843px; top: 482.026px; transform: scaleX(0.913043);">Human</span><span dir="ltr" style="left: 149.298px; top: 482.026px;">-</span><span dir="ltr" style="left: 154.911px; top: 482.026px; transform: scaleX(1.03284);">to</span><span dir="ltr" style="left: 170.72px; top: 482.026px;">-</span><span dir="ltr" style="left: 176.333px; top: 482.026px; transform: scaleX(1.01147);">human transmission of Ebola virus in West Africa was interrupted in 2016 but the risk of re</span><span dir="ltr" style="left: 917.322px; top: 482.026px;">-</span><span dir="ltr" style="left: 95.1843px; top: 504.426px; transform: scaleX(0.892064);">emergence of the disease is real. Thus, efforts to develop a safe and effective vaccine against Ebola virus disease </span><span dir="ltr" style="left: 95.1843px; top: 526.426px; transform: scaleX(1.00762);">with a durable prophylactic effect in c</span><span dir="ltr" style="left: 398.613px; top: 526.426px; transform: scaleX(0.965913);">ommunities must continue. The Partnership for Research on Ebola </span><span dir="ltr" style="left: 95.1843px; top: 548.826px; transform: scaleX(0.959905);">Vaccinations (PREVAC) is an international consortium including the French Institute of Health and Medical </span><span dir="ltr" style="left: 95.1843px; top: 571.226px; transform: scaleX(0.959342);">Research, the London School of Hygiene &amp; Tropical Medicine, the US National Institutes</span> <span dir="ltr" style="left: 791.822px; top: 571.226px; transform: scaleX(0.978885);">of Health, health </span><span dir="ltr" style="left: 95.1843px; top: 593.626px; transform: scaleX(0.89466);">authorities and scientists from Guinea, Liberia, Mali and Sierra Leone, a non</span><span dir="ltr" style="left: 649.492px; top: 593.626px;">-</span><span dir="ltr" style="left: 655.104px; top: 593.626px; transform: scaleX(0.916368);">governmental organisation (Alliance </span><span dir="ltr" style="left: 95.1843px; top: 616.026px; transform: scaleX(0.913464);">for International Medical Action), and Merck, Johnson &amp; Johnson and Bavarian Nordic companies.</span></span><br /><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 95.1843px; top: 662.026px; transform: scaleX(0.910087);">The PREVAC trial is a phase</span> <span dir="ltr" style="left: 315.242px; top: 662.026px; transform: scaleX(0.960445);">IIB, randomised, placebo controlled, multicentre trial evaluating the safety and </span><span dir="ltr" style="left: 95.1843px; top: 684.426px; transform: scaleX(0.922663);">immunogenicity over 12 months of three vaccine strategies in children and adults. Participants are randomised </span><span dir="ltr" style="left: 95.1843px; top: 706.426px; transform: scaleX(0.965273);">to one of five groups: (i) vaccination with Ad26.ZEBOV prime and</span> <span dir="ltr" style="left: 614.216px; top: 706.426px; transform: scaleX(0.953837);">MVA</span><span dir="ltr" style="left: 650.901px; top: 706.426px;">-</span><span dir="ltr" style="left: 656.514px; top: 706.426px; transform: scaleX(0.855128);">BN</span><span dir="ltr" style="left: 678.32px; top: 706.426px;">-</span><span dir="ltr" style="left: 683.933px; top: 706.426px; transform: scaleX(0.974709);">Filo boost, (ii) vaccination with </span><span dir="ltr" style="left: 95.1843px; top: 728.826px; transform: scaleX(0.830148);">rVSV</span><span dir="ltr" style="left: 130.804px; top: 728.826px;">&Delta;</span><span dir="ltr" style="left: 141.152px; top: 728.826px;">G</span><span dir="ltr" style="left: 152.718px; top: 728.826px;">-</span><span dir="ltr" style="left: 158.33px; top: 728.826px; transform: scaleX(0.803054);">ZEBOV</span><span dir="ltr" style="left: 208.38px; top: 728.826px;">-</span><span dir="ltr" style="left: 213.993px; top: 728.826px; transform: scaleX(0.9598);">GP prime and a boost of the same vaccine, (iii) vaccination with rVSV</span><span dir="ltr" style="left: 756.427px; top: 728.826px;">&Delta;</span><span dir="ltr" style="left: 766.775px; top: 728.826px;">G</span><span dir="ltr" style="left: 778.341px; top: 728.826px;">-</span><span dir="ltr" style="left: 783.954px; top: 728.826px; transform: scaleX(0.803054);">ZEBOV</span><span dir="ltr" style="left: 834.004px; top: 728.826px;">-</span><span dir="ltr" style="left: 839.616px; top: 728.826px; transform: scaleX(0.886605);">GP vaccine </span><span dir="ltr" style="left: 95.1843px; top: 751.226px; transform: scaleX(0.91181);">without boost, (iv) placebo group 1 and (v) placebo group 2. Preliminary phases started in Liberia and Guinea in </span><span dir="ltr" style="left: 95.1843px; top: 773.626px; transform: scaleX(0.915459);">March 2017; the main phase of the trial evaluating the five regimens begun in Liberia, Guinea Sierra Leone and </span><span dir="ltr" style="left: 95.1843px; top: 796.026px; transform: scaleX(0.947823);">Mali in April</span> <span dir="ltr" style="left: 189.375px; top: 796.026px; transform: scaleX(0.923972);">2018 with an enrolment targets of 1,400 adults and 1,400 children.</span></span><br /><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 95.1843px; top: 842.026px; transform: scaleX(0.875071);">The</span> <span dir="ltr" style="left: 131.961px; top: 842.026px; transform: scaleX(0.796886);">PREVAC</span><span dir="ltr" style="left: 191.123px; top: 842.026px;">-</span><span dir="ltr" style="left: 196.736px; top: 842.026px; transform: scaleX(0.83231);">UP</span> <span dir="ltr" style="left: 222.514px; top: 842.026px; transform: scaleX(0.93964);">trial consists in a long term follow</span><span dir="ltr" style="left: 475.93px; top: 842.026px;">-</span><span dir="ltr" style="left: 481.543px; top: 842.026px; transform: scaleX(0.92547);">up of patients included in the PREVAC trial to determine</span> <span dir="ltr" style="left: 907.609px; top: 842.026px; transform: scaleX(0.939752);">(i) </span><span dir="ltr" style="left: 95.1843px; top: 864.026px; transform: scaleX(0.936035);">the long</span><span dir="ltr" style="left: 156.382px; top: 864.026px;">-</span><span dir="ltr" style="left: 161.995px; top: 864.026px; transform: scaleX(0.933816);">term immunogenicity and safety and (ii) durability of humoral and</span> <span dir="ltr" style="left: 658.503px; top: 864.026px; transform: scaleX(0.907448);">cellular immune responses of Ebola </span><span dir="ltr" style="left: 95.1843px; top: 886.426px; transform: scaleX(0.901408);">vaccine regimes over 60 months.</span> <span dir="ltr" style="left: 342.03px; top: 886.426px; transform: scaleX(0.912211);">In this postdoc, we propose to address these two question using mathematical </span><span dir="ltr" style="left: 95.1843px; top: 908.826px; transform: scaleX(0.919085);">modeling and statistics.</span></span><br /><br /></p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Mission confiée</h4>
    	<div class="list-group-item-text text-justify">
    		<p style="text-align: justify;"><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 95.1843px; top: 954.426px; transform: scaleX(0.875071);">The</span> <span dir="ltr" style="left: 129.687px; top: 954.426px; transform: scaleX(0.820741);">SISTM</span> <span dir="ltr" style="left: 182.576px; top: 954.426px; transform: scaleX(0.938574);">(Statistics in Systems and Translational Medicine)</span> <span dir="ltr" style="left: 569.46px; top: 954.426px; transform: scaleX(0.947584);">team</span> <span dir="ltr" style="left: 614.964px; top: 954.426px; transform: scaleX(0.960036);">directed by Pr. Rod</span><span dir="ltr" style="left: 765.084px; top: 954.426px; transform: scaleX(0.952101);">olphe Thi&eacute;baut is </span><span dir="ltr" style="left: 95.1843px; top: 977.226px; transform: scaleX(0.934725);">involved</span> <span dir="ltr" style="left: 161.844px; top: 977.226px; transform: scaleX(0.968949);">in</span> <span dir="ltr" style="left: 179.314px; top: 977.226px; transform: scaleX(0.811262);">PREVAC and PREVAC</span><span dir="ltr" style="left: 332.944px; top: 977.226px;">-</span><span dir="ltr" style="left: 338.557px; top: 977.226px; transform: scaleX(0.899267);">UP and had been also involved in many international consortium for EBOLA, </span><span dir="ltr" style="left: 95.1843px; top: 999.626px; transform: scaleX(0.925275);">ie.</span> <span dir="ltr" style="left: 121.893px; top: 999.626px; transform: scaleX(0.832006);">EBOVAC1</span> <span dir="ltr" style="left: 197.409px; top: 999.626px; transform: scaleX(0.85378);">and EBOVAC3</span> <span dir="ltr" style="left: 305.346px; top: 999.626px; transform: scaleX(0.914739);">and</span> <span dir="ltr" style="left: 337.768px; top: 999.626px; transform: scaleX(0.881357);">coordinates EBOVAC2</span><span dir="ltr" style="left: 501.451px; top: 999.626px; transform: scaleX(0.926724);">. In this context one of its main goal is to</span> <span dir="ltr" style="left: 808.954px; top: 999.626px; transform: scaleX(0.935146);">conduct</span> <span dir="ltr" style="left: 873.539px; top: 999.626px; transform: scaleX(0.975623);">the </span><span dir="ltr" style="left: 95.1843px; top: 1022.03px; transform: scaleX(0.963148);">analysis and the modelling of</span> <span dir="ltr" style="left: 330.687px; top: 1022.03px; transform: scaleX(0.971212);">the immune response to</span> <span dir="ltr" style="left: 529.262px; top: 1022.03px; transform: scaleX(0.947517);">the Ebola vaccine strategy, using</span> <span dir="ltr" style="left: 790.545px; top: 1022.03px; transform: scaleX(0.932295);">data</span> <span dir="ltr" style="left: 830.902px; top: 1022.03px; transform: scaleX(0.931264);">including </span><span dir="ltr" style="left: 95.1843px; top: 1044.03px; transform: scaleX(0.971036);">immunological substudies recording many biomarkers (cell phenotype,</span> <span dir="ltr" style="left: 660.868px; top: 1044.03px; transform: scaleX(0.967578);">functionality</span><span dir="ltr" style="left: 754.764px; top: 1044.03px; transform: scaleX(0.956335);">, gene expression, </span><span dir="ltr" style="left: 95.1843px; top: 1066.43px; transform: scaleX(0.954769);">antibody titers</span><span dir="ltr" style="left: 204.495px; top: 1066.43px; transform: scaleX(0.829127);">...</span><span dir="ltr" style="left: 217.153px; top: 1066.43px; transform: scaleX(0.907943);">).</span></span><br /><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 95.1843px; top: 1112.43px; transform: scaleX(0.907058);">SISTM is a team belonging to INSERM</span> <span dir="ltr" style="left: 389.213px; top: 1112.43px; transform: scaleX(0.903634);">U1219</span> <span dir="ltr" style="left: 443.926px; top: 1112.43px; transform: scaleX(0.930602);">Bordeaux Population Health</span> <span dir="ltr" style="left: 662.761px; top: 1112.43px; transform: scaleX(0.914739);">and</span> <span dir="ltr" style="left: 696.589px; top: 1112.43px; transform: scaleX(0.849447);">INRIA</span> <span dir="ltr" style="left: 744.007px; top: 1112.43px; transform: scaleX(0.897881);">Bordeaux Sud</span><span dir="ltr" style="left: 848.618px; top: 1112.43px;">-</span><span dir="ltr" style="left: 854.23px; top: 1112.43px; transform: scaleX(0.901502);">Ouest </span><span dir="ltr" style="left: 95.1843px; top: 1134.83px; transform: scaleX(0.945403);">research institutes.</span> <span dir="ltr" style="left: 248.478px; top: 1134.83px; transform: scaleX(0.95656);">The group is</span> <span dir="ltr" style="left: 353.603px; top: 1134.83px; transform: scaleX(0.928421);">dedicated</span> <span dir="ltr" style="left: 434.994px; top: 1134.83px; transform: scaleX(0.992336);">to the analysis and the modelling of the data generated in </span><span dir="ltr" style="left: 95.1843px; top: 1157.23px; transform: scaleX(0.952875);">epidemiology and medicine with a special focus on vaccines and immune interventions in HIV and other </span><span dir="ltr" style="left: 95.1843px; top: 1179.63px; transform: scaleX(0.89797);">infectious diseases. Its expertise is mainly in bios</span><span dir="ltr" style="left: 453.819px; top: 1179.63px; transform: scaleX(0.901114);">tatistics with a special emphasis on dynamical models based </span><span dir="ltr" style="left: 95.1843px; top: 1202.03px; transform: scaleX(0.910954);">on ODE and statistical learning using moderately high dimensional data.</span></span></p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Principales activités</h4>
    	<div class="list-group-item-text text-justify">
    		<p style="text-align: justify;"><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 95.1843px; top: 198.026px; transform: scaleX(0.939867);">The main objective of this postdoc position</span> <span dir="ltr" style="left: 425.872px; top: 198.026px; transform: scaleX(0.96882);">will be</span> <span dir="ltr" style="left: 480.358px; top: 198.026px; transform: scaleX(0.948358);">to use the data gathered through the</span> <span dir="ltr" style="left: 767.416px; top: 198.026px; transform: scaleX(0.810445);">PREVA</span><span dir="ltr" style="left: 816.803px; top: 198.026px;">C</span><span dir="ltr" style="left: 826.578px; top: 198.026px; transform: scaleX(0.834718);">/PREVAC</span><span dir="ltr" style="left: 892.822px; top: 198.026px;">-</span><span dir="ltr" style="left: 95.1843px; top: 220.426px; transform: scaleX(0.83231);">UP</span> <span dir="ltr" style="left: 120.209px; top: 220.426px;">t</span><span dir="ltr" style="left: 126.35px; top: 220.426px; transform: scaleX(0.913004);">rials</span> <span dir="ltr" style="left: 160.898px; top: 220.426px; transform: scaleX(1.03284);">to</span> <span dir="ltr" style="left: 180.498px; top: 220.426px; transform: scaleX(0.916736);">build and fit a model of the immune response to the Ebola vaccine in order to better characterize </span><span dir="ltr" style="left: 95.1843px; top: 242.826px; transform: scaleX(0.938693);">the response (duration)</span> <span dir="ltr" style="left: 278.8px; top: 242.826px; transform: scaleX(0.914739);">and</span> <span dir="ltr" style="left: 312.048px; top: 242.826px; transform: scaleX(0.944732);">better understand the mechanism of its establishment</span><span dir="ltr" style="left: 724.451px; top: 242.826px;">.</span> <span dir="ltr" style="left: 734.282px; top: 242.826px; transform: scaleX(0.967898);">Model estimation will </span><span dir="ltr" style="left: 95.1843px; top: 265.226px; transform: scaleX(0.924303);">be performed using maximum likelihood approac</span><span dir="ltr" style="left: 461.821px; top: 265.226px; transform: scaleX(0.922411);">h as implementer with the SAEM algorithm, for example in </span><span dir="ltr" style="left: 95.1843px; top: 287.626px; transform: scaleX(0.945848);">the MONOLIX software of the Lixoft suite. Methodological development will consist in building a series of </span><span dir="ltr" style="left: 95.1843px; top: 310.026px; transform: scaleX(0.925247);">model building strategies.</span></span></p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
		<h4 class="list-group-item-heading">Compétences</h4>
		<div class="list-group-item-text text-justify">
			<p style="text-align: justify;"><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 104.118px; top: 947.626px; transform: scaleX(0.912548);">The candidate should h</span><span dir="ltr" style="left: 268.311px; top: 947.626px; transform: scaleX(0.958774);">old</span> <span dir="ltr" style="left: 295.879px; top: 947.626px; transform: scaleX(0.809611);">a P</span><span dir="ltr" style="left: 318.193px; top: 947.626px;">h</span><span dir="ltr" style="left: 327.825px; top: 947.626px; transform: scaleX(0.907797);">D in mathematics, physics or statistics.</span> <span dir="ltr" style="left: 618.335px; top: 947.626px; transform: scaleX(0.926433);">We are looking for</span> <span dir="ltr" style="left: 760.306px; top: 947.626px;">a</span> <span dir="ltr" style="left: 773.148px; top: 947.626px; transform: scaleX(0.942676);">highly motivated </span><span dir="ltr" style="left: 95.1843px; top: 970.026px; transform: scaleX(0.992988);">candidate with an outstanding potential and</span> <span dir="ltr" style="left: 454.771px; top: 970.026px; transform: scaleX(0.975654);">a strong background in statistics</span> <span dir="ltr" style="left: 719.292px; top: 970.026px; transform: scaleX(1.01276);">and a deep interest in </span><span dir="ltr" style="left: 95.1843px; top: 992.426px; transform: scaleX(0.924797);">immunology and</span> <span dir="ltr" style="left: 223.463px; top: 992.426px; transform: scaleX(0.925977);">biological application</span><span dir="ltr" style="left: 380.567px; top: 992.426px;">.</span> <span dir="ltr" style="left: 388.695px; top: 992.426px; transform: scaleX(0.90262);">Proven</span> <span dir="ltr" style="left: 444.76px; top: 992.426px; transform: scaleX(0.909208);">experience in</span> <span dir="ltr" style="left: 547.642px; top: 992.426px; transform: scaleX(0.860123);">R language</span> <span dir="ltr" style="left: 632.012px; top: 992.426px; transform: scaleX(0.896018);">is required. The ideal candidates are </span><span dir="ltr" style="left: 95.1843px; top: 1014.83px; transform: scaleX(0.936125);">able to</span> <span dir="ltr" style="left: 150.99px; top: 1014.83px; transform: scaleX(0.913323);">work effectively as part of a team, but also to develop and pursue independent ideas. The successful </span><span dir="ltr" style="left: 95.1843px; top: 1037.23px; transform: scaleX(0.92268);">candidates are expected to conduct innovative research at the highest international level.</span></span><br /><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 95.1843px; top: 1082.83px; transform: scaleX(0.955039);">Experience in</span> <span dir="ltr" style="left: 212.241px; top: 1082.83px; transform: scaleX(0.98439);">modelling and</span> <span dir="ltr" style="left: 335.583px; top: 1082.83px; transform: scaleX(1.02061);">applications in biology is highly</span> <span dir="ltr" style="left: 602.892px; top: 1082.83px; transform: scaleX(1.0144);">recommended and previous work in</span></span><br /><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 95.1843px; top: 1105.23px; transform: scaleX(0.925666);">immunology/Vaccinology, systems biology</span> <span dir="ltr" style="left: 415.534px; top: 1105.23px; transform: scaleX(0.951897);">will be</span> <span dir="ltr" style="left: 468.305px; top: 1105.23px; transform: scaleX(0.924315);">highly appreciated</span><span dir="ltr" style="left: 606.253px; top: 1105.23px;">.</span></span><br /><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 95.1843px; top: 1150.83px; transform: scaleX(0.918063);">The expected starting date</span> <span dir="ltr" style="left: 299.359px; top: 1150.83px; transform: scaleX(0.880913);">can be as soon as possible.</span> </span></p>
		</div>
	</div>
	    
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Rémunération</h4>
    	<div class="list-group-item-text text-justify">
    		<p><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span dir="ltr" style="left: 503.638px; top: 1150.83px; transform: scaleX(0.923086);">Salary will follow Inserm rates</span> <span dir="ltr" style="left: 731.452px; top: 1150.83px; transform: scaleX(0.91727);">and can be negotiated </span><span dir="ltr" style="left: 95.1843px; top: 1173.23px; transform: scaleX(1.03284);">to</span> <span dir="ltr" style="left: 115.138px; top: 1173.23px; transform: scaleX(0.909175);">be higher depending on previous experience and skills.</span></span></p>
    	</div>
    </div>
      
                    </div>
                </div>
        
                          <div id="right" class="col-sm-5 bloc-right">	
               
                	<div class="row">
                		<div class="col-sm-12" style="padding:15px;margin-bottom :10px;">
                     	                        	                           		<a href="2022-05478.html#" class="btn btn-lg btn-danger btn-postuler-footer" style="width:100%" data-toggle="modal" data-target="#registerOffre">Postuler</a>
                        	                    			
            			</div>
            		</div>
        		    	<h4 >Partager</h4>

		<ul class="social">
		<li><a target="_blank" href="https://www.facebook.com/sharer.php?u=http://jobs.inria.fr/public/classic/fr/offres/2022-05478&title=Offre+d%27emploi+Inria&description=Post-Doctoral Research Visit F/M Post-doctoral research fellowship in modelling of the immune response to Ebola vaccine" class="a-facebook btn btn-sm btn-danger"> <i class="fa fa-facebook"></i> </a></li>
		<li><a target="_blank" href="https://www.linkedin.com/shareArticle?mini=true&url=http://jobs.inria.fr/public/classic/fr/offres/2022-05478&title=Offre d'emploi Inria&summary=Post-Doctoral Research Visit F/M Post-doctoral research fellowship in modelling of the immune response to Ebola vaccine" class="a-linkedin btn btn-sm btn-danger"> <i class="fa fa-linkedin"></i> </a></li>
		<li><a target="_blank" href="http://twitter.com/share?hashtags=Jobs.inria.fr,Emploi,Bordeaux&text=Offre d'emploi Inria : Post-Doctoral Research Visit F/M Post-doctoral research fellowship in modelling of the immune response to Ebola vaccine%0A&url=http://jobs.inria.fr/public/classic/fr/offres/2022-05478" class="a-twitter btn btn-sm btn-danger"> <i class="fa fa-twitter"></i> </a></li>
		<li><a target="_blank" href="mailto:?body=Offre d'emploi Inria :%0A Post-Doctoral Research Visit F/M Post-doctoral research fellowship in modelling of the immune response to Ebola vaccine%0A%0A http://jobs.inria.fr/public/classic/fr/offres/2022-05478&subject=Offre d'emploi Inria: Post-Doctoral Research Visit F/M Post-doctoral research fellowship in modelling of the immune response to Ebola vaccine" class="a-envelope btn btn-sm btn-danger"> <i class="fa fa-envelope"></i> </a></li>
	</ul>
	
        				
	<h4 >Informations générales</h4>
	<ul class="nomargin">
									<li><strong>Thème/Domaine :</strong>
											Optimisation, apprentissage et méthodes statistiques
						<br/>										
											Statistiques (Big data)
													(BAP E)
																
				</li>
							
				<li><strong>Ville :</strong>
			Bordeaux
		</li>
				
				<li><strong>Centre Inria :</strong>
							<a class="a-inria" target="_blank" href="http://www.inria.fr/centre/bordeaux">Centre Inria de l&#039;université de Bordeaux</a>
					</li>  
						
					<li><strong>Date de prise de fonction souhaitée :</strong>
				2022-12-01
			</li>
							<li><strong>Durée de contrat :</strong>
					12 mois
				</li>
							
				<li><strong>Date limite pour postuler :</strong>
			2023-03-31				
		</li>
			</ul>
	
        				
	<h4 >Contacts</h4>
	<ul class="nomargin">
				<li><strong>Equipe Inria :</strong>
							<a class="a-inria" href="https://www.inria.fr/equipes/SISTM" target="_blank">SISTM</a>    	
								</li>
												<li>
			<strong>Recruteur :</strong>
			<br/>
			Prague Melanie
			/
			<a class="a-inria" href="mailto:melanie.prague@inria.fr">melanie.prague@inria.fr</a>
		</li>
	    	</ul>

        				
	
        			<div class="grand-item-offre">
    					<h4 class="list-group-item-heading">A propos d&#039;Inria</h4>
    					<p class="list-group-item-text text-justify">
    		            Inria est l’institut national de recherche dédié aux sciences et technologies du numérique. Il emploie 2600 personnes. Ses 200 équipes-projets agiles, en général communes avec des partenaires académiques, impliquent plus de 3500 scientifiques pour relever les défis du numérique, souvent à l’interface d’autres disciplines. L’institut fait appel à de nombreux talents dans plus d’une quarantaine de métiers différents. 900 personnels d’appui à la recherche et à l’innovation contribuent à faire émerger et grandir des projets scientifiques ou entrepreneuriaux qui impactent le monde. Inria travaille avec de nombreuses entreprises et a accompagné la création de plus de 180 start-up. L&#039;institut s&#039;eﬀorce ainsi de répondre aux enjeux de la transformation numérique de la science, de la société et de l&#039;économie.
    					</p>
    				</div>
            			
	<h4 >Consignes pour postuler</h4>
	<div class="text-justify">
		<p><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;">Thank you to send:</span><br /><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;">- CV</span><br /><span style="font-family: arial, helvetica, sans-serif; font-size: 10pt;">- Cover letter</span><br /><br /></p>
	</div>
				
	<p class="text-justify">
		<strong>Sécurité défense : </strong>
		<br/>
		Ce poste est susceptible d’être affecté dans une zone à régime restrictif (ZRR), telle que définie dans le décret n°2011-1425 relatif à la protection du potentiel scientifique et technique de la nation (PPST). L’autorisation d’accès à une zone est délivrée par le chef d’établissement, après avis ministériel favorable, tel que défini dans l’arrêté du 03 juillet 2012, relatif à la PPST. Un avis ministériel défavorable pour un poste affecté dans une ZRR aurait pour conséquence l’annulation du recrutement.
    </p>
             	
    <p class="text-justify">
    	<strong> Politique de recrutement :</strong>
        <br/>
		Dans le cadre de sa politique diversité, tous les postes Inria sont accessibles aux personnes en situation de handicap.
    </p>
        <p class="text-justify alert alert-warning">
		<b>Attention</b>: Les candidatures doivent être déposées en ligne sur le site Inria. Le traitement des candidatures adressées par d'autres canaux n'est pas garanti.
    </p>
    
             </div>
        </div>
    </div>
</div>

<!-- Modal Creer son compte -->
<div class="modal fade" id="registerOffre" tabindex="-1" role="dialog" aria-labelledby="myModalLabel">
    <div class="modal-dialog" role="document">
        <div class="modal-content ">
            
            <div class="modal-body">
              	<div class="row">
                  	<div class="col-md-6 pull-right">
                  		<button type="button" class="close" data-dismiss="modal" aria-label="Close"><i class="fa fa-remove"></i></button>
                  	</div>
            	</div>
            	<div class="row">
					<div class="col-md-6">
						<div class="form-group">
                        <p class="h4-inria list-group-item-text text-center">
                        Je crée mon compte
                        </p> 
                        <p class="h4 list-group-item-text text-center "> 
             			<i class="fa fa-info-circle"></i>
             			 Pour suivre votre candidature
                        </p>
            			<p class="h3 list-group-item-text text-center">
                           	<a href="https://jobs.inria.fr/public/fr/register?ref=2022-05478"  class=" btn btn-danger">
	        	        		<i class="fa fa-plus"></i> Créer un compte
           					</a>
        				</p>
             			
                        </div>
       				</div>
           
           			<div class="col-md-6"  style="border-left: 1px solid #CCC;">
           				<div class="form-group">
           			
                        <p class="h4-inria list-group-item-text text-center">
							J&#039;ai déjà un compte!
                        </p> 
            			<p class="h3 list-group-item-text text-center">
                           	<a href="https://jobs.inria.fr/public/classic/fr/offres/2022-05478/postuler"  class=" btn btn-danger">
	        	        		<i class="fa fa-sign-in"></i> Se connecter
           					</a>
        				</p>
        				</div>
       				</div>
            	</div>
        	</div>
            <div class="modal-footer" style="border: none;">
                <button type="button" class="btn btn-default" data-dismiss="modal">Annuler </button>
            </div>
            
        </div>
    </div>
</div>

<script type="text/javascript" src="../../../../library/bootstrap-select-1.12.2/dist/js/bootstrap-select.min.js"></script>
        <script type="text/javascript" src="../../../../js/moment.js"></script>
		<script type="text/javascript" src="../../../../js/bootstrap-datetimepicker.js"></script>
		<script src="../../../../js/cookiechoices.js"></script>
		<script>
				var textCookie = "En poursuivant votre navigation sur ce site vous acceptez l'utilisation des cookies pour vous proposer des contenus et services adaptés à vos centres d'intérêts.";
		var textBtnCookie = 'En savoir plus';
		var textAccept = "J'accepte";
				document.addEventListener('DOMContentLoaded', function(event){cookieChoices.showCookieConsentBar(
				textCookie, textAccept, textBtnCookie, '/public/fr/mentions-legales');
		});
		</script>

		<script type="text/javascript">

		 ScrollToTop = function() {
             var screen = $(window).scrollTop();
             if (screen > 100) {
               $('.scrollup').fadeIn();
             } else {
               $('.scrollup').fadeOut();
             }
         }
		 $('.scrollup').on('mouseover', function(){
             $(this).addClass('scrollup-mouseover');
             $(this).removeClass('scrollup-mouseout');
            });
         $('.scrollup').on('mouseout', function(){
             $(this).addClass('scrollup-mouseout');
             $(this).removeClass('scrollup-mouseover');
            });

         $('.scrollup').on('click',function () {
             $("html, body").animate({ scrollTop: 0 }, 500);

             return false;
         });

         StopAnimation = function() {
            $("html, body").bind("scroll mousedown DOMMouseScroll mousewheel keyup", function(){
                $('html, body').stop();
            });
         }

         $(window).scroll(function() {
             ScrollToTop();
             StopAnimation();
         });

		</script>


        <!-- Piwik -->
                <script type="text/javascript">
          var _paq = _paq || [];
          /* tracker methods like "setCustomDimension" should be called before "trackPageView" */
          _paq.push(['trackPageView']);
          _paq.push(['enableLinkTracking']);
          (function() {
            var u="//piwik.inria.fr/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', '74']);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
          })();
        </script>
                <!-- End Piwik Code -->
    <script type="text/javascript">
    $(document).ready( function(){
        $("postulerOffre").on('click', function(){
            $('#postulerOffre').modal();
        });
    });
    </script>
    
</div>

<footer class="footer">
    <div class="col-md-12 text-center">
            <span class="text-center text-links-footer">
            <a href="../../../fr/contact.html"  target="_blank">Contact</a>&nbsp;&nbsp;|&nbsp;
            <a href="../../../fr/mentions-legales.html" target="_blank">Mentions légales</a>
                        </span>
    </div>
</footer>
<script src="https://commons.inria.fr/bootstrap/ie10-fixup/ie10-viewport-bug-workaround.js"></script><script type="text/javascript" src="../../../../library/bootstrap-select-1.12.2/dist/js/bootstrap-select.min.js"></script>
        <script type="text/javascript" src="../../../../js/moment.js"></script>
		<script type="text/javascript" src="../../../../js/bootstrap-datetimepicker.js"></script>
		<script src="../../../../js/cookiechoices.js"></script>
		<script>
				var textCookie = "En poursuivant votre navigation sur ce site vous acceptez l'utilisation des cookies pour vous proposer des contenus et services adaptés à vos centres d'intérêts.";
		var textBtnCookie = 'En savoir plus';
		var textAccept = "J'accepte";
				document.addEventListener('DOMContentLoaded', function(event){cookieChoices.showCookieConsentBar(
				textCookie, textAccept, textBtnCookie, '/public/fr/mentions-legales');
		});
		</script>

		<script type="text/javascript">

		 ScrollToTop = function() {
             var screen = $(window).scrollTop();
             if (screen > 100) {
               $('.scrollup').fadeIn();
             } else {
               $('.scrollup').fadeOut();
             }
         }
		 $('.scrollup').on('mouseover', function(){
             $(this).addClass('scrollup-mouseover');
             $(this).removeClass('scrollup-mouseout');
            });
         $('.scrollup').on('mouseout', function(){
             $(this).addClass('scrollup-mouseout');
             $(this).removeClass('scrollup-mouseover');
            });

         $('.scrollup').on('click',function () {
             $("html, body").animate({ scrollTop: 0 }, 500);

             return false;
         });

         StopAnimation = function() {
            $("html, body").bind("scroll mousedown DOMMouseScroll mousewheel keyup", function(){
                $('html, body').stop();
            });
         }

         $(window).scroll(function() {
             ScrollToTop();
             StopAnimation();
         });

		</script>


        <!-- Piwik -->
                <script type="text/javascript">
          var _paq = _paq || [];
          /* tracker methods like "setCustomDimension" should be called before "trackPageView" */
          _paq.push(['trackPageView']);
          _paq.push(['enableLinkTracking']);
          (function() {
            var u="//piwik.inria.fr/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', '74']);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
          })();
        </script>
                <!-- End Piwik Code -->
    <script type="text/javascript">
    $(document).ready( function(){
        $("postulerOffre").on('click', function(){
            $('#postulerOffre').modal();
        });
    });
    </script>
</body>
</html>
